Skip to main content

Peer Review reports

From: Overexpression of SLC6A1 associates with drug resistance and poor prognosis in prostate cancer

Original Submission
2 Feb 2020 Submitted Original manuscript
24 Feb 2020 Author responded Author comments - Weide Zhong
16 Mar 2020 Author responded Author comments - Weide Zhong
18 Feb 2020 Reviewed Reviewer Report - Yoshimitsu Akiyama
21 Feb 2020 Reviewed Reviewer Report - Till Braunschweig
7 Mar 2020 Reviewed Reviewer Report - Yoshimitsu Akiyama
26 Feb 2020 Reviewed Reviewer Report - Till Braunschweig
Resubmission - Version 2
24 Feb 2020 Submitted Manuscript version 2
Publishing
23 Mar 2020 Editorially accepted
6 Apr 2020 Article published 10.1186/s12885-020-06776-7

You can find further information about peer review here.

Back to article page
\